EUVIMEDEUVIMED entdecken
Crossref

Clinical and genetic characteristics of Dent's disease type 1 in Europe

Carla Burballa, Gerard Cantero-Recasens, Larisa Prikhodina, Francesca Lugani, Karlpeter Schlingmann, Petr V Ananin, Martine Besouw, Detlef Bockenhauer, Leire Madariaga, Aurelia Bertholet-Thomas, Francesca Taroni, Mattia Parolin und 15 weitere

Nephrology Dialysis Transplantation · 31.05.2023 · 38 (6) · 1497-1507

DOI: 10.1093/ndt/gfac310 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 28.11.2022. Verfasst von Carla Burballa und 26 weiteren Autor:innen. Beteiligte Einrichtung: Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain. Hauptthemen laut MEDLINE: Nephrocalcinosis, Dent Disease, Kidney Calculi, Renal Insufficiency. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: ASDENT, Red de Investigación Renal, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dent's disease type 1 (DD1) is a rare X-linked nephropathy caused by CLCN5 mutations, characterized by proximal tubule dysfunction, including low molecular weight proteinuria (LMWP), hypercalciuria, nephrolithiasis–nephrocalcinosis, progressive chronic kidney disease (CKD) and kidney failure (KF). Current management is symptomatic and does not prevent disease progression. Here we describe the contemporary DD1 picture across Europe to highlight its unmet needs.

Methods

A physician-based anonymous international e-survey supported by several European nephrology networks/societies was conducted. Questions focused on DD1 clinical features, diagnostic procedure and mutation spectra.

Results

A total of 207 DD1 male patients were reported; clinical data were available for 163 with confirmed CLCN5 mutations. Proteinuria was the most common manifestation (49.1%). During follow-up, all patients showed LMWP, 66.4% nephrocalcinosis, 44.4% hypercalciuria and 26.4% nephrolithiasis. After 5.5 years, ≈50% of patients presented with renal dysfunction, 20.7% developed CKD stage ≥3 and 11.1% developed KF. At the last visit, hypercalciuria was more frequent in paediatric patients than in adults (73.4% versus 19.0%). Conversely, nephrolithiasis, nephrocalcinosis and renal dysfunction were more prominent in adults. Furthermore, CKD progressed with age. Despite no clear phenotype/genotype correlation, decreased glomerular filtration rate was more frequent in subjects with CLCN5 mutations affecting the pore or CBS domains compared with those with early-stop mutations.

Conclusions

Results from this large DD1 cohort confirm previous findings and provide new insights regarding age and genotype impact on CKD progression. Our data strongly support that DD1 should be considered in male patients with CKD, nephrocalcinosis/hypercalciuria and non-nephrotic proteinuria and provide additional support for new research opportunities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NephrocalcinosisDent DiseaseKidney CalculiRenal InsufficiencyRenal Insufficiency, ChronicMaleHumansHypercalciuriaMutationEuropeProteinuriaChloride Channels

Stichwörter der Autor:innen

CLCN5 geneDent's disease 1 (DD1)low molecular weight proteinurianephrocalcinosistubulopathy

Substanzen

Chloride Channels

Autor:innen und Institutionen

  • Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain.
  • Veltishev Research and Clinical Institute for Pediatrics, Pirogov Russian National Research Medical University, Moscow, Russia.
  • IRCCS Istituto G. Gaslini, Genova, Italy.
  • University Children's Hospital, Münster, Germany.
  • Scientific Centre of Children Health 2, Moscow, Russia.
  • University Medical Center, Groningen, The Netherlands.

ORCID-Profile: Gema Ariceta

Förderung

  • ASDENT
  • Red de Investigación Renal
  • European Union

Zitieren

APA

Burballa, C., Cantero-Recasens, G., Prikhodina, L., Lugani, F., Schlingmann, K., Ananin, P. V., Besouw, M., Bockenhauer, D., Madariaga, L., Bertholet-Thomas, A., Taroni, F., Parolin, M., Conlon, P., Emma, F., Del Prete, D., Chauveau, D., Koster-Kamphuis, L., Fila, M., Pasini, A., …, & DENT study group (2023). Clinical and genetic characteristics of Dent's disease type 1 in Europe. Nephrology Dialysis Transplantation, 38(6), 1497-1507. https://doi.org/10.1093/ndt/gfac310

Vancouver

Burballa C, Cantero-Recasens G, Prikhodina L, Lugani F, Schlingmann K, Ananin PV, et al. Clinical and genetic characteristics of Dent's disease type 1 in Europe. Nephrology Dialysis Transplantation. 2023;38(6):1497-1507. doi:10.1093/ndt/gfac310

BibTeX
@article{Burballa2023,
  author = {Burballa, Carla and Cantero-Recasens, Gerard and Prikhodina, Larisa and Lugani, Francesca and Schlingmann, Karlpeter and Ananin, Petr V and Besouw, Martine and Bockenhauer, Detlef and Madariaga, Leire and Bertholet-Thomas, Aurelia and Taroni, Francesca and Parolin, Mattia and Conlon, Peter and Emma, Francesco and Del Prete, Dorella and Chauveau, Dominique and Koster-Kamphuis, Linda and Fila, Marc and Pasini, Andrea and Castro, Isabel and Colussi, Giacomo and Gil, Marta and Mohidin, Barian and Wlodkowski, Tanja and Schaefer, Franz and Ariceta, Gema and DENT study group, DENT study group},
  title = {Clinical and genetic characteristics of Dent's disease type 1 in Europe},
  journal = {Nephrology Dialysis Transplantation},
  year = {2023},
  volume = {38},
  number = {6},
  pages = {1497--1507},
  doi = {10.1093/ndt/gfac310}
}
Kostenlos starten →